Semaglutide-induced Subclinical Hypothyroidism: A Case Report
Open Access
- 30 April 2023
- journal article
- Published by European Open Science Publishing in European Journal of Biology and Biotechnology
- Vol. 5 (3), 8-9
- https://doi.org/10.24018/ejmed.2023.5.3.1743
Abstract
Introduction/Background: Drug-induced hypothyroidism is well established in the literature. I describe the first case of symptomatic subclinical hypothyroidism (SCH) in a thyroidectomy woman with diabetes mellitus 2 receiving therapy with per os levothyroxine and sc semaglutide (Ozempic). Case Presentation: A 37-year-old overweight and thyroidectomy woman with diabetes mellitus 2 was admitted to our hospital with complaints of increasing fatigue, weakness and shortness of breath. She received levothyroxine (150 μcg per day), sc semaglutide (1 mg per week the last six months), and rosuvastatin (20 mg per day). A detailed clinical examination and laboratory tests revealed, among others, an elevated TSH serum level (92-98 mIU/L) with normal serum FT3 and FT4 levels on first and next measurements. Based on the possible diagnosis of semaglutide-induced SCH, semaglutide was withdrawn. Thyroid dysfunction was restored (serum TSH: 1.8 mIU/L) after two months with a significant improvement in symptoms. Conclusion: An influence of sc semaglutide on thyroid function is possible. Thyroid function tests are suggested in patients receiving both per os levothyroxine and sc semaglutide.Keywords
This publication has 10 references indexed in Scilit:
- Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled TrialsFrontiers in Endocrinology, 2022
- Obesity and Thyroid AxisInternational Journal of Environmental Research and Public Health, 2021
- Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trialExpert Opinion on Drug Metabolism & Toxicology, 2021
- Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesDiabetes, Obesity and Metabolism, 2021
- Effects of thyroid status on glycated hemoglobinIndian Journal of Endocrinology and Metabolism, 2017
- Hypothyroidism and obesity: An intriguing linkIndian Journal of Endocrinology and Metabolism, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- The Effect of Thyroid Disorders on Lipid Levels and MetabolismMedical Clinics of North America, 2012
- Escitalopram-induced subclinical hypothyroidism. A case reportHormones, 2012
- Drug-Induced Thyroid DisordersDrug Safety, 1995